simvastatin has been researched along with piracetam in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Parle, M; Vasudevan, M | 1 |
Costa, RA; de Souza-Pinto, NC; Fernandes, MP; Vercesi, AE | 1 |
Chen, T; Li, MQ; Liu, L; Zhang, WW | 1 |
Antunes, NJ; Campos, R; De Nucci, G; Dezena, RMB; Ilha, J; Mendes, GD; Moreno, RA; Rosa, PCP | 1 |
6 other study(ies) available for simvastatin and piracetam
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): an Ayurvedic preparation.
Topics: Animals; Avoidance Learning; Brain; Cholesterol; Cholinesterase Inhibitors; Cholinesterases; Diazepam; GABA Modulators; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medicine, Ayurvedic; Memory; Mice; Muscarinic Antagonists; Nootropic Agents; Phyllanthus emblica; Piracetam; Scopolamine; Simvastatin | 2007 |
Protective effects of l-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin.
Topics: Carnitine; Cell Line, Tumor; Cyclosporine; Drug Synergism; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Piracetam; Simvastatin; Superoxides | 2013 |
[Protective effects of levetiracetam and simvastatin on pilocarpine-induced epilepsy in rat models].
Topics: Animals; Calpain; Disease Models, Animal; Epilepsy; Hippocampus; Levetiracetam; Pilocarpine; Piracetam; Rats; Seizures; Simvastatin | 2015 |
Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Humans; Male; Piracetam; Simvastatin | 2020 |